Palbonix 125mg (Palbociclib)


Product Description:

Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:
• an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.
• fulvestrant in women with disease progression following endocrine therapy.

Product Features:

Product Name : Palbonix
Generic Name : Palbociclib
Formulation : Capsules
Available Pack Size : 21’s Pot
Available Strengths : 125mg
Categories : Anti-viral, Biotech Products, Drugs to treat Hepatitis
Manufacturer : Beacon Pharmaceuticals Ltd.


There are no reviews yet.

Be the first to review “Palbonix 125mg (Palbociclib)”

Your email address will not be published.